Source: PharmiWeb

Med Fusion: GenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FISH Tests

GenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FI...

Read full article »
Med Fusion's Competitors | Med Fusion's News | Med Fusion's Financials
Stay up-to-date with the latest news on med fusion
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Jon L. Hart's photo - CEO of med fusion

CEO

Jon L. Hart

CEO Approval Rating

68/100

Read more
Stay up-to-date with the latest news on med fusion